These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 28181752)

  • 1. Shall the pharmaceutical companies decide which trials to perform?
    Rogne S
    Tidsskr Nor Laegeforen; 2017 Feb; 137(3):183. PubMed ID: 28181752
    [No Abstract]   [Full Text] [Related]  

  • 2. Innovation-Innovation Tradeoffs in Drug Pricing.
    Sachs RE; Frakt AB
    Ann Intern Med; 2016 Dec; 165(12):871-872. PubMed ID: 27723887
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmaceutical research and development spending Ranked by percentage of revenue spent on research in 2015 ($ in millions).
    Mod Healthc; 2016 Oct; 46(41):35. PubMed ID: 30398790
    [No Abstract]   [Full Text] [Related]  

  • 4. Notable deals in the pharmaceutical industry in the fourth quarter of 2016.
    D'Souza P
    Drugs Today (Barc); 2017 Jan; 53(1):75-82. PubMed ID: 28387386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of COVID-19 on pharmaceutical external innovation sourcing.
    Robke L; Berghauser Pont L; Bongard J; Wurzer S; Smietana K; Moss R
    Nat Rev Drug Discov; 2020 Dec; 19(12):829. PubMed ID: 33173230
    [No Abstract]   [Full Text] [Related]  

  • 6. Delinking Investment in Antibiotic Research and Development from Sales Revenues: The Challenges of Transforming a Promising Idea into Reality.
    Outterson K; Gopinathan U; Clift C; So AD; Morel CM; Røttingen JA
    PLoS Med; 2016 Jun; 13(6):e1002043. PubMed ID: 27299990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical company-sponsored drug trials: what are we to believe?
    Shekelle P
    J Clin Epidemiol; 2010 Feb; 63(2):126-7. PubMed ID: 19836207
    [No Abstract]   [Full Text] [Related]  

  • 8. Industry sponsorship and selection of comparators in randomized clinical trials.
    Lathyris DN; Patsopoulos NA; Salanti G; Ioannidis JP
    Eur J Clin Invest; 2010 Feb; 40(2):172-82. PubMed ID: 20050879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Support for trials of promising medications through the Pharmaceutical Benefits Scheme. A proposal for a new authority category.
    Glasziou PP
    Med J Aust; 1995 Jan; 162(1):33-6. PubMed ID: 7605432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Good manners for the pharmaceutical industry.
    Rustin GJ; Crowther D
    Lancet; 1997 Aug; 350(9074):371. PubMed ID: 9251670
    [No Abstract]   [Full Text] [Related]  

  • 11. Commentary: Reconsidering Pharmaceutical Research and Development Investments.
    Gagnon MA
    Healthc Policy; 2023 Feb; 18(3):25-30. PubMed ID: 36917451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor.
    Flacco ME; Manzoli L; Boccia S; Capasso L; Aleksovska K; Rosso A; Scaioli G; De Vito C; Siliquini R; Villari P; Ioannidis JP
    J Clin Epidemiol; 2015 Jul; 68(7):811-20. PubMed ID: 25748073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large clinical trials in epilepsy: funding by the NIH versus pharmaceutical industry.
    Privitera M
    Epilepsy Res; 2006 Jan; 68(1):52-6. PubMed ID: 16377139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trials with statistically nonsignificant results.
    Allison DB; Cope MB
    JAMA; 2010 Sep; 304(9):965; author reply 965. PubMed ID: 20810373
    [No Abstract]   [Full Text] [Related]  

  • 15. [Industry-promoted research and the significance principle].
    Klin Monbl Augenheilkd; 2001 May; 218(5):A90-1. PubMed ID: 11417352
    [No Abstract]   [Full Text] [Related]  

  • 16. How clean was the KLEAN trial?
    Bellman P
    Lancet; 2006 Nov; 368(9547):1570-1; author reply 1571. PubMed ID: 17084747
    [No Abstract]   [Full Text] [Related]  

  • 17. Sponsorship, antidepressant dose, and outcome in major depressive disorder: meta-analysis of randomized controlled trials.
    Sinyor M; Schaffer A; Smart KA; Levitt AJ; Lanctôt KL; Grysman NH
    J Clin Psychiatry; 2012 Feb; 73(2):e277-87. PubMed ID: 22401489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Data bases of clinical trials.
    Albrich JM
    N Engl J Med; 1999 Jan; 340(1):65-6. PubMed ID: 9882223
    [No Abstract]   [Full Text] [Related]  

  • 19. Mega-trials for blockbusters.
    Ioannidis JP
    JAMA; 2013 Jan; 309(3):239-40. PubMed ID: 23321760
    [No Abstract]   [Full Text] [Related]  

  • 20. An updated survey for the 2007-2013 period of randomized controlled trials for psoriasis: treatment modalities, study designs, comparators, outcome measures and sponsorship.
    Manalo IF; Gilbert KE; Wu JJ
    J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1945-50. PubMed ID: 25763768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.